-
Product Insights
NewMAP Kinase Activated Protein Kinase 2 – Drugs In Development, 2024
The MAP Kinase Activated Protein Kinase 2 pipeline drugs market research report outlays comprehensive information on the MAP Kinase Activated Protein Kinase 2 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Musculoskeletal Disorders, Oncology, Immunology, and Respiratory which include indications of Ankylosing Spondylitis (Bekhterev's Disease), Psoriatic Arthritis, Bladder Cancer, Head And Neck Cancer, Rheumatoid Arthritis, and Acute...
-
Product Insights
NewAditya Birla Chemicals Map Ta Phut Complex, Thailand
Empower your strategies with our Aditya Birla Chemicals Map Ta Phut Complex, Thailand report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Reasons to buy Gain a gateway to actionable insights and competitive advantage. Acquire a...
-
Product Insights
NewMAP Kinase Interacting Serine/Threonine Protein Kinase 1 – Drugs In Development, 2024
The MAP Kinase Interacting Serine/Threonine Protein Kinase 1 pipeline drugs market research report outlays comprehensive information on the MAP Kinase Interacting Serine/Threonine Protein Kinase 1 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology, and Central Nervous System which include indications of Solid Tumor, Triple-Negative Breast Cancer (TNBC), Migraine, and Neuropathic Pain (Neuralgia). It also reviews key...
-
Product Insights
NewMAP Kinase Interacting Serine/Threonine Protein Kinase 2 – Drugs In Development, 2024
The MAP Kinase Interacting Serine/Threonine Protein Kinase 2 pipeline drugs market research report outlays comprehensive information on the MAP Kinase Interacting Serine/Threonine Protein Kinase 2 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology, Central Nervous System, and Dermatology which include indications of Triple-Negative Breast Cancer (TNBC), Non-Small Cell Lung Cancer, Migraine, Neuropathic Pain (Neuralgia), and Dermatology....
-
Company Insights
NewGenetic Analysis AS Pipeline Insight and Competitive Landscape, 2024
Empower your strategies with our Genetic Analysis AS Pipeline Insight and Competitive Landscape, 2024 report and make more profitable business decisions. Genetic Analysis AS (Genetic Analysis) is a molecular diagnostic company that mapping of microbiota by utilizing the GA-map technology to develop IVD tests in various diseases. Its products include service products and lab products. Service and lab products include dysbiosis test Lx reagent kit, Covid-19 fecal test reagent kit. It offers services include research and diagnostics, companion diagnostics, laboratory...
-
Company Insights
NewKardium Inc Pipeline Insight and Competitive Landscape, 2024
Empower your strategies with our Kardium Inc Pipeline Insight and Competitive Landscape, 2024 report and make more profitable business decisions. Kardium Inc (Kardium) is a medical device company that develops ground breaking medical device for the diagnosis and treatment of atrial fibrillation. The company offers the globe mapping and ablation system, an investigational medical device used in the diagnosis and treatment of atrial fibrillation. Its globe mapping and ablation system contains the globe catheter, the globe software console and the...
-
Product Insights
NewAcutus Medical Inc Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our Acutus Medical Inc Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. Acutus Medical Inc (Acutus Medical) is engaged in providing electrophysiological mapping systems for the treatment of cardiac arrhythmias. It offers various products which include AcQMap system, AcQMap 3D imaging and mapping catheter; and AcQGuide steerable sheath. Acutus Medical’s electrofunctional mapping systems provides solutions to diagnose and treat atrial fibrillation. The company products enable physicians to visualize CT-quality scan, map...
-
Macroeconomic Analysis
NewGlobal Risk Report Quarterly Update – Q1 2024
Global Risk Report Overview In Q1 2024, global geopolitical risks are at a tipping point with key hotspots threatening international stability. Conflicts in the Middle East, which contribute to shipping disruptions and inflationary pressures threaten global trade. Meanwhile, recent developments on the Korean peninsula, including Pyongyang's shift in reunification goals have raised concerns about rising tensions. These dynamics highlight the critical need for strategic diplomacy and risk management efforts to navigate today's global landscape. the potential dangers of uncontrollable self-aware...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Gen1E-1124 in Kidney Disease (Nephropathy)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Gen1E-1124 in Kidney Disease (Nephropathy) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Gen1E-1124 in Kidney Disease (Nephropathy) Drug Details: Gen1E-1124 is under...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – BDTX-1535 in High-Grade Glioma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - BDTX-1535 in High-Grade Glioma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. BDTX-1535 in High-Grade Glioma Drug Details: BDTX-1535 is under development for...